About Tim Coleman
Form D filings for O'Ryan Therapeutics in 2023 list Tim Coleman as executive officer and director.
Tim Coleman first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Tim Coleman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Tim Coleman works with at each company, as listed on that company's latest Form D.
O'Ryan Therapeutics, Inc. · Form D, Sep 8, 2023
MP
Michael Parnell
President and CEO, director